TITLE

Bioactivity-Guided Identification and Cell Signaling Technology to Delineate the Lactate Dehydrogenase A Inhibition Effects of Spatholobus suberectus on Breast Cancer

AUTHOR(S)
Wang, Zhiyu; Wang, Dongmei; Han, Shouwei; Wang, Neng; Mo, Feizhi; Loo, Tjing Yung; Shen, Jiangang; Huang, Hui; Chen, Jianping
PUB. DATE
February 2013
SOURCE
PLoS ONE;Feb2013, Vol. 8 Issue 2, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Aerobic glycolysis is an important feature of cancer cells. In recent years, lactate dehydrogenase A (LDH-A) is emerging as a novel therapeutic target for cancer treatment. Seeking LDH-A inhibitors from natural resources has been paid much attention for drug discovery. Spatholobus suberectus (SS) is a common herbal medicine used in China for treating blood-stasis related diseases such as cancer. This study aims to explore the potential medicinal application of SS for LDH-A inhibition on breast cancer and to determine its bioactive compounds. We found that SS manifested apoptosis-inducing, cell cycle arresting and anti-LDH-A activities in both estrogen-dependent human MCF-7 cells and estrogen-independent MDA-MB-231 cell. Oral herbal extracts (1 g/kg/d) administration attenuated tumor growth and LDH-A expression in both breast cancer xenografts. Bioactivity-guided fractionation finally identified epigallocatechin as a key compound in SS inhibiting LDH-A activity. Further studies revealed that LDH-A plays a critical role in mediating the apoptosis-induction effects of epigallocatechin. The inhibited LDH-A activities by epigallocatechin is attributed to disassociation of Hsp90 from HIF-1α and subsequent accelerated HIF-1α proteasome degradation. In vivo study also demonstrated that epigallocatechin could significantly inhibit breast cancer growth, HIF-1α/LDH-A expression and trigger apoptosis without bringing toxic effects. The preclinical study thus suggests that the potential medicinal application of SS for inhibiting cancer LDH-A activity and the possibility to consider epigallocatechin as a lead compound to develop LDH-A inhibitors. Future studies of SS for chemoprevention or chemosensitization against breast cancer are thus warranted.
ACCESSION #
87624784

 

Related Articles

  • Chemosensitizing and cytotoxic effects of 2-deoxy-D-glucose on breast cancer cells. Fanjie Zhang; Aft, Rebecca L. // Journal of Cancer Research & Therapeutics;Apr-Jun2009 Supplement, Vol. 5 Issue S13, pS41 

    Background: Accelerated glucose uptake for anerobic glycolysis is one of the major metabolic changes found in malignant cells. This property has been exploited for imaging malignancies and as a possible anticancer therapy. The nonmetabolizable glucose analog 2-deoxyglucose (2 DG) interferes with...

  • Induction of Apoptosis in Human Breast Cancer Cells via Caspase Pathway by Vernodalin Isolated from Centratherum anthelminticum (L.) Seeds. Looi, Chung Yeng; Arya, Aditya; Cheah, Foo Kit; Muharram, Bushra; Leong, Kok Hoong; Mohamad, Khalit; Wong, Won Fen; Rai, Nitika; Mustafa, Mohd Rais // PLoS ONE;Feb2013, Vol. 8 Issue 2, p1 

    Background: Centratherum anthelminticum (L.) seeds (CA) is a well known medicinal herb in Indian sub-continent. We recently reported anti-oxidant property of chloroform fraction of Centratherum anthelminticum (L.) seeds (CACF) by inhibiting tumor necrosis factor-α (TNF-α)-induced growth...

  • Warburg effect in chemosensitivity: Targeting lactate dehydrogenase-A re-sensitizes Taxol-resistant cancer cells to Taxol. Ming Zhou; Yuhua Zhao; Yan Ding; Hao Liu; Zixing Liu; Fodstad, Oystein; Riker, Adam I.; Kamarajugadda, Sushama; Jianrong Lu; Owen, Laurie B.; Ledoux, Susan P.; Ming Tan // Molecular Cancer;2010, Vol. 9, p33 

    Background: Taxol is one of the most effective chemotherapeutic agents for the treatment of patients with breast cancer. Despite impressive clinical responses initially, the majority of patients eventually develop resistance to Taxol. Lactate dehydrogenase-A (LDH-A) is one of the predominant...

  • Antitumor Activity of New Quinoxaline Analogues and Its Complexes. Ismaeel, A. A.; Yousif, N. F.; Ali, K. F.; Mousa, F. H. // Pakistan Journal of Chemistry;2013, Vol. 3 Issue 4, p1 

    This study shows synthesis of a new quinoxaline derivatives (LH) and preparation of copper (Cu-LH) and cobalt (Co-LH) complexes and studying the effect of these compounds on the activity of lactate dehydrogenase (LDH) a primary enzyme to the process of anaerobic glycolysis which is the source of...

  • Human Lactate Dehydrogenase A Inhibitors: A Molecular Dynamics Investigation. Shi, Yun; Pinto, B. Mario // PLoS ONE;Jan2014, Vol. 9 Issue 1, p1 

    Lactate dehydrogenase A (LDHA) is an important enzyme in fermentative glycolysis, generating most energy for cancer cells that rely on anaerobic respiration even under normal oxygen concentrations. This renders LDHA a promising molecular target for the treatment of various cancers. Several...

  • Antitumor activity of phenethyl isothiocyanate in HER2-positive breast cancer models. Gupta, Parul; Srivastava, Sanjay K. // BMC Medicine;2012, Vol. 10 Issue 1, p80 

    Background: HER2 is an oncogene, expression of which leads to poor prognosis in 30% of breast cancer patients. Although trastuzumab is apparently an effective therapy against HER2-positive tumors, its systemic toxicity and resistance in the majority of patients restricts its applicability. In...

  • MCF-7 Cells--Changing the Course of Breast Cancer Research and Care for 45 Years. Lee, Adrian V.; Oesterreich, Stefi; Davidson, Nancy E. // JNCI: Journal of the National Cancer Institute;7/15/2015, Vol. 107 Issue 7, p1 

    It is 45 years since a pleural effusion from a patient with metastatic breast cancer led to the generation of the MCF-7 breast cancer cell line. MCF-7 is the most studied human breast cancer cell line in the world, and results from this cell line have had a fundamental impact upon breast cancer...

  • 1,1-Bis(3′-indolyl)-1-(p-substituted phenyl) methanes induce autophagic cell death in estrogen receptor negative breast cancer. Vanderlaag, Kathy; Yunpeng Su; Frankel, Arthur E.; Burghardt, Robert C.; Barhoumi, Rola; Chadalapaka, Gayathri; Jutooru, Indira; Safe, Stephen // BMC Cancer;2010, Vol. 10, p669 

    Background: A novel series of methylene-substituted DIMs (C-DIMs), namely 1,1-bis(3'-indolyl)-1-(p-substituted phenyl)methanes containing t-butyl (DIM-C-pPhtBu) and phenyl (DIM-C-pPhC6H5) groups inhibit proliferation of invasive estrogen receptor-negative MDA-MB-231 and MDA-MB-453 human breast...

  • In vitro antiproliferative and apoptosis-inducing properties of a mononuclear copper(II) complex with dppz ligand, in two genotypically different breast cancer cell lines. Dhivya, Rajakumar; Jaividhya, Paramasivam; Riyasdeen, Anvarbatcha; Palaniandavar, Mallayan; Mathan, Ganeshan; Akbarsha, Mohammad // BioMetals;Oct2015, Vol. 28 Issue 5, p929 

    In the background that there is concerted effort to discover newer metal-based cancer chemotherapeutic agents that could overcome the limitations in cisplatin and that copper, a biocompatible and redox-active metal, offers potential as alternative to cisplatin, the present study was undertaken...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics